These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 7122248)

  • 41. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical and epidemiological aspects of controlled short-term chemotherapy].
    Khomenko AG
    Probl Tuberk; 1998; (4):16-20. PubMed ID: 9771030
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemotherapy for tuberculosis.
    Nardell EA
    Ann Intern Med; 1981 Jan; 94(1):138. PubMed ID: 7447212
    [No Abstract]   [Full Text] [Related]  

  • 44. [Current chemotherapy of tuberculosis and its effectiveness in Bulgaria].
    Radanov R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(4):237-40. PubMed ID: 6278567
    [No Abstract]   [Full Text] [Related]  

  • 45. [The efficacy of 6 months' chemotherapy of newly diagnosed patients with pulmonary tuberculosis].
    Gamperis Iu; Gaĭdamonene D; Dimbelene M; Pavlitska L; Nevirovska Z
    Probl Tuberk; 1990; (6):60-1. PubMed ID: 2217108
    [No Abstract]   [Full Text] [Related]  

  • 46. [B-lymphocytes and the level of circulating immune complexes in pulmonary tuberculosis patients treated with chemotherapy and vitamins].
    Volosevich GV
    Probl Tuberk; 1983 Jul; (7):20-2. PubMed ID: 6605532
    [No Abstract]   [Full Text] [Related]  

  • 47. [Organization and methods of correcting the chemotherapy of destructive pulmonary tuberculosis].
    Kovalenko NI; Ginzburg TS; Shapovalov VP; Taranenko MI
    Probl Tuberk; 1987; (9):35-8. PubMed ID: 3422965
    [No Abstract]   [Full Text] [Related]  

  • 48. [Efficacy of alpha-tocopherol in the complex treatment of newly diagnosed patients with destructive tuberculosis of the lungs].
    Panasiuk AV; Suslov EI; Penenko OR; Davyda RS
    Vrach Delo; 1986 Apr; (4):63-6. PubMed ID: 3716344
    [No Abstract]   [Full Text] [Related]  

  • 49. [Short-term intensive therapy of destructive pulmonary tuberculosis].
    Bondarev IM; Zhigalina LI; Kunichan AD
    Probl Tuberk; 1980 Dec; (12):57-9. PubMed ID: 7220536
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical recovery of patients with pulmonary tuberculosis in long-term antibacterial therapy].
    Morozova LN
    Klin Med (Mosk); 1967 Dec; 45(12):43-8. PubMed ID: 5606967
    [No Abstract]   [Full Text] [Related]  

  • 51. [Intermittent intravenous chemotherapy of patients with newly detected pulmonary tuberculosis].
    Serebrova NI; Kononenko VG; Sharapova LN; Kiskevich MI; Savelova SA
    Probl Tuberk; 1975; (3):51-4. PubMed ID: 1135203
    [No Abstract]   [Full Text] [Related]  

  • 52. [Late results of an experimental pilot for short-term tuberculosis chemotherapy in cases that are positive by microscopy].
    Anastasatu C; Bercea O; Corlan E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1984; 33(4):321-34. PubMed ID: 6097991
    [No Abstract]   [Full Text] [Related]  

  • 53. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of antitubercular chemotherapy on immune status within the first 3 months of the start of short-term treatment].
    Cioflec D; Ion N; Tudorache V; Hudiţeanu O; Luţă V; Chira Z; Neagoe D; Stoienescu D; Jemna I; Sfetcu V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(2):137-44. PubMed ID: 2849189
    [No Abstract]   [Full Text] [Related]  

  • 55. [Blood T-lymphocyte functional activity in pulmonary tuberculosis patients undergoing chemotherapeutic agent and vitamin treatment].
    Volosevich GV
    Probl Tuberk; 1982 Mar; (3):47-50. PubMed ID: 6979747
    [No Abstract]   [Full Text] [Related]  

  • 56. Shortened chemotherapy for pulmonary tuberculosis.
    Abeles H; Rodescu D; Williams MH
    N Engl J Med; 1982 Dec; 307(24):1527. PubMed ID: 7144824
    [No Abstract]   [Full Text] [Related]  

  • 57. [Differential pathogenetic therapy in the complex treatment of patients with destructive pulmonary tuberculosis].
    Molotkov VN; Ivaniuta OM; Bystritskaia VI; Mel'nik VN
    Probl Tuberk; 1982 Feb; (2):45-8. PubMed ID: 7063479
    [No Abstract]   [Full Text] [Related]  

  • 58. [Characteristics of the course of pulmonary tuberculosis caused by Mycobacterium bovis].
    Kochetov BI; Dolzhanskiĭ VM; Nemsadze MN
    Probl Tuberk; 1980 Feb; (2):23-6. PubMed ID: 6990406
    [No Abstract]   [Full Text] [Related]  

  • 59. [New cases of pulmonary tuberculosis treatment within DOTS strategy].
    Zhangireev AA; Ismailov ShSh; Berikova EM
    Probl Tuberk; 2000; (3):23-5. PubMed ID: 10900979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Results of bronchoscopic examinations of tuberculosis patients undergoing complex chemotherapy].
    Abduraşitova TV
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(3):185-8. PubMed ID: 6273992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.